In Vitro Maturation of Human Eggs

Launched by NATIONAL FOUNDATION FOR FERTILITY RESEARCH · Aug 3, 2015

Keywords

ClinConnect Summary

The novel device (IVM media system), is designed to support nuclear maturation of immature oocytes recovered after minimal ovarian stimulation with no LH/hCG administration, and improve oocyte competence. This may result in development of a greater number of embryos to the blastocyst stage.

FSH is administered starting on cycle day 3 to stimulate follicle growth. When the leading follicle reaches 12-14 mm, egg retrieval will be scheduled. No hCG/LH trigger will be administered. Specially designed maturation media is used to collect and culture the immature eggs once recovered from the foll...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Infertile women who desire to conceive and come to CCRM for infertility treatment using IVF will be candidates for this study.
• • Women with PCOS
• • Patients can be of any race, culture, sexual orientation or ethnicity.
• Exclusion Criteria:
• • Minors are excluded from participation in this study.
• • Women with a BMI greater than 40
• • Women whose health is such that becoming pregnant carries risk significantly greater than healthy women are excluded from this study, unless they use a gestational carrier under the direction of their physician.

Trial Officials